The annual Conference on Retroviruses and Opportunistic Infections (CROI 2016) took place in Boston, USA from 22-25 February 2016.

Conference highlights

PrEP

Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016.

Conference bulletins

Conference bulletins, available in English, French, Italian, Portuguese, Russian and Spanish.

Achieving the 90-90-90 target

Botswana close to reaching the 90-90-90 testing and treatment targets.


Transgender people

Trans people are at high risk for HIV, but too little is known about prevention and treatment.

HIV prevention

Vaginal rings containing an anti-HIV drug are moderately effective in preventing HIV.

HIV epidemiology

The lifetime risk of being diagnosed with HIV in the US has decreased but varies widely among population.


Side-effects

Tenofovir treatment raises the risk of broken bones.

Infectiousness

People with HIV considerably overestimate their chance of infecting someone.

New HIV treatment

Combination of long-acting injectable anti-HIV drugs work well as HIV maintenance therapy.


aidsmap news from CROI 2016

← First123Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Tweets from CROI 2016

Official conference website

Find out more on the official conference website.

Visit the CROI 2016 website >

NAM's coverage of CROI 2016 has been made possible thanks to support from Gilead Sciences and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.